Ticker > Company >

Shelter Pharma share price

Shelter Pharma Ltd.

BSE: 543963 SECTOR: Pharmaceuticals & Drugs  14k   43   5

51.50
-3.49 (-6.35%)
BSE: 13 Nov 04:01 PM

Price Summary

Today's High

₹ 53.5

Today's Low

₹ 51.5

52 Week High

₹ 80.9

52 Week Low

₹ 41.1

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

59.53 Cr.

Enterprise Value

55.07 Cr.

No. of Shares

1.16 Cr.

P/E

9.6

P/B

1.71

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  30.17

CASH

5.04 Cr.

DEBT

0.58 Cr.

Promoter Holding

54.97 %

EPS (TTM)

₹  5.36

Sales Growth

10.71%

ROE

25.58 %

ROCE

33.62%

Profit Growth

19.1 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.71%
3 Year21.19%
5 Year7.61%

Profit Growth

1 Year19.1%
3 Year431.91%
5 Year152.71%

ROE%

1 Year25.58%
3 Year33.25%
5 Year20.35%

ROCE %

1 Year33.62%
3 Year43.13%
5 Year26.51%

Debt/Equity

0.0166

Price to Cash Flow

-32.18

Interest Cover Ratio

32.4211

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 54.97 0.00
Mar 2024 56.89 0.00
Sep 2023 56.89 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 21.1940654447264% for the Past 3 years.
  • The company has significantly decreased its debt by 1.2068 Cr.
  • Company has been maintaining healthy ROE of 33.2487864101079% over the past 3 years.
  • Company has been maintaining healthy ROCE of 43.1336061920588% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 32.4211.
  • Company has a healthy liquidity position with current ratio of 20.1498.
  • The company has a high promoter holding of 54.97%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 34.4855466092006.

 Limitations

  • Company has negative cash flow from operations of -1.8502.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 30.07 22.48 30.06 36.15 40.02
Total Expenditure 29.82 22.29 27.32 28.09 31.24
Operating Profit 0.24 0.19 2.74 8.07 8.79
Other Income 0.01 0.01 0.02 0 0.01
Interest 0.01 0.02 0.08 0.03 0.26
Depreciation 0.13 0.12 0.17 0.16 0.25
Exceptional Items 0 0 0 -0.9 0
Profit Before Tax 0.11 0.06 2.51 6.98 8.28
Tax 0.03 0.02 0.67 1.78 2.08
Net Profit 0.08 0.04 1.84 5.21 6.2
Adjusted EPS (Rs.) 0.11 0.05 2.37 6.72 5.36

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.45 0.48 0.48 7.74 11.56
Total Reserves 6.53 6.63 8.44 6.81 24.26
Borrowings 0 0 0.06 0.48 0.57
Other N/C liabilities 0.18 0.19 0.14 0.17 0.02
Current liabilities 3.47 2.9 3.71 6.25 1.47
Total Liabilities 10.63 10.2 12.84 21.45 37.88
Assets
Net Block 1.77 1.57 1.45 1.85 3.58
Capital WIP 0 0 0.55 0 0
Intangible WIP 0 0 0 0 0
Investments 0.68 0.68 0.68 0.68 0.68
Loans & Advances 0.12 0.08 0.33 0.21 3.9
Other N/C Assets 0 0 0 0 0
Current Assets 8.07 7.88 9.83 18.72 29.72
Total Assets 10.63 10.2 12.84 21.45 37.88
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.11 0.06 2.51 7.05 8.4
Adjustment -0.18 -0.18 0.05 0.17 0.58
Changes in Assets & Liabilities -0.2 -0.17 -2.04 -8.19 -9.26
Tax Paid 0 0 0 0 -1.57
Operating Cash Flow -0.27 -0.28 0.52 -0.96 -1.85
Investing Cash Flow 0.29 0.03 -0.85 0.11 -4.54
Financing Cash Flow 0 0.48 0.06 1.18 11.01
Net Cash Flow 0.02 0.23 -0.27 0.33 4.61

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Mar 2024% Sep 2024%
promoters 56.89 56.89 54.97
dr.nusrat mustakim sabuga... 5.54 5.54 5.54
mustaqim nisarahmed sabug... 12.60 12.60 12.60
parvezbanu mohamed rafiq ... 5.54 5.54 5.54
shakil nisarahmed sabugar... 15.23 15.23 15.23
suraiya m sakil sabugar 5.54 5.54 5.54
zubedabibi nisarahmed sab... 12.46 12.46 10.54
PARTICULARS Sep 2023% Mar 2024% Sep 2024%
investors 43.11 43.11 45.03
mayuri shripal vora 1.25 1.32 1.32
malani wealth advisors pr... - 10.10 -
achathkonrensis sales age... 10.10 - -
kruti sevanti doshi 1.38 - -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Shelter Pharma Stock Price Analysis and Quick Research Report. Is Shelter Pharma an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Shelter Pharma and its performance over the period of time. Shelter Pharma stock price today is Rs 51.5.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Shelter Pharma cash from the operating activity was Rs -1.8502 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Shelter Pharma has a Debt to Equity ratio of 0.0166 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Shelter Pharma , the EPS growth was -20.2142 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Shelter Pharma has OPM of 21.95218237559 % which is a good sign for profitability.
     
  • ROE: Shelter Pharma have a healthy ROE of 25.5779 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Shelter Pharma is Rs 51.5. One can use valuation calculators of ticker to know if Shelter Pharma share price is undervalued or overvalued.
Last Updated on:
Brief about Shelter Pharma
X